EBS EMERGENT BIOSOLUTIONS INC
2026Q1 · CUSIP 29089Q105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
187
Δ holders QoQ
+5
Breadth percentile
Top 43%
Whale holders
96
Δ whales
+2
Inst. holding value
$354M
New positions
36
Closed positions
31
Price momentum (1Q)
-24.0%
Put / Call
3/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q2 | Top 13% | -13.7% | -25.8% |
| 2020Q3 | Top 2% | +35.0% | -34.6% |
| 2020Q2 | Top 10% | -35.0% | -8.2% |
| 2020Q1 | Top 3% | +49.0% | -3.1% |
| 2019Q3 | Top 14% | +18.8% | +63.0% |
| 2018Q4 | Top 12% | -34.0% | -32.7% |
| 2018Q3 | Top 17% | -10.6% | -38.9% |
| 2018Q1 | Top 4% | +16.6% | +30.9% |
Options Sentiment
Put holders
3
QoQ: -1
Call holders
4
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.19
EPS YoY
—
Revenue (TTM)
$0.7B
Revenue YoY
-29.9%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)